Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV002260608 | SCV002540718 | benign | Rett syndrome | 2022-05-10 | reviewed by expert panel | curation | The allele frequency of the p.Ile125= variant in MECP2 (NM_004992) is 0.394% in South Asian sub population in gnomAD, which is high enough to be classified as Benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The p.Ile125= variant is observed in at least 2 unaffected individuals (PMID 11055898, 20479760, RettBASE proband id 4623, 4624) (BS2). In summary, the p.Ile125= variant in MECP2 is classified as Benign based on the ACMG/AMP criteria applied (BA1, BS2). |
Eurofins Ntd Llc |
RCV000081201 | SCV000113109 | benign | not specified | 2013-09-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000081201 | SCV000170216 | benign | not specified | 2013-05-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000081201 | SCV000247965 | benign | not specified | 2018-04-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000081201 | SCV000310760 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001087820 | SCV000556728 | benign | Severe neonatal-onset encephalopathy with microcephaly | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000712283 | SCV000842733 | benign | not provided | 2017-11-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000716805 | SCV000847649 | likely benign | History of neurodevelopmental disorder | 2016-08-19 | criteria provided, single submitter | clinical testing | Synonymous alterations with insufficient evidence to classify as benign |
Ce |
RCV000712283 | SCV001150519 | uncertain significance | not provided | 2016-10-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000081201 | SCV003800987 | benign | not specified | 2023-01-25 | criteria provided, single submitter | clinical testing | |
Centre for Population Genomics, |
RCV002260608 | SCV004808977 | benign | Rett syndrome | 2024-03-08 | criteria provided, single submitter | curation | This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 3.0 (BA1). |
Rett |
RCV000081201 | SCV000188072 | benign | not specified | 2011-11-01 | no assertion criteria provided | curation | |
Clinical Molecular Genetics Laboratory, |
RCV000081201 | SCV000257508 | benign | not specified | 2007-05-09 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000712283 | SCV001930665 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000712283 | SCV001965926 | likely benign | not provided | no assertion criteria provided | clinical testing |